The Evolving Role of Venous Stents and How New Data Will Effect The Clinical Landscape

The Evolving Role of Venous Stents and How New Data Will Effect The Clinical Landscape

On-Demand Webcast

Raghu Kolluri, MD, MS, RVT - Moderator 
President - The Society for Vascular Medicine
System Medical Director - Vascular Medicine & Vascular Labs, OhioHealth Heart and Vascular
Clinical Professor of Medicine - Ohio University HCOM
Director - Syntropic Corelab
Athens, Ohio

Stephen A. Black, MD, FRCS(Ed), FEBVS
Consultant Vascular Surgeon
Guy’s and St Thomas’ Hospital NHS Foundation Trust
London, United Kingdom

Kush R. Desai, MD, FSIR
Associate Professor of Radiology, Surgery, and Medicine
Division of Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Erin H. Murphy, MD, FACS
Director, Venous and Lymphatic Institute
Sanger Heart and Vascular, Atrium Health
Charlotte, North Carolina

provider statement

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

 For questions regarding this educational activity, please call 609-371-1137 or email

intended learners

This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, nurses, PAs, vascular and interventional techs. 


After participating in this activity, participants should be better able to:

  • Identify and address the challenges associated to venous disease, and how it is different from arterial disease
  • Understand the role of IVUS as it relates to venous stenting
  • Compare brand new and previously presented data on stenting to treat venous disease, and identify how the data effects clinical decisions
  • Understand the properties of nitinol and the impact on venous disease
Claiming Credit

To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation by June 30, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: June 30, 2020
Expiration Date: September 15, 2021
Estimated Time to Complete: 1 hour

There is no fee associated with this activity.


NACCME would like to thank the following company who has supported the "The Evolving Role of Venous Stents and How New Data Will Effect The Clinical Landscape" through an educational grant: Medtronic

Continuing Education

 In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this internet live/enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.


NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.


The Evolving Role of Venous Stents and How New Data Will Effect The Clinical Landscape taking place from June 30, 2020 to June 30, 2021 has been approved for 1.0 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).


This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.


This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.


NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewers

Peter Oettgen, MD
Preventive Cardiology
Beth Israel Deaconess Medical Center
Boston, MA

Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Chris Bolwell, Samantha Conforti, Randy Robbin, Margie Stefan, and Colleen Waters. 

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

The faculty has reported the following:

Dr. Black: Advisory Board—BSCI, Gore, Medtronic, Phillips-Volcano, Vesper; Consultant/Speakers' Bureau—BD Bard, BSCI, Cook, Gore, Medtronic, Optimed, Phillips-Volcano, Veryan, Vesper

Dr. Desai: Advisory Board—Medtronic; Consultant—Becton Dickinson, Boston Scientific, Cardinal Health, Cook Medical, Philips, W.L. Gore; Speakers' Bureau—Becton Dickinson, Boston Scientific 

Dr. Kolluri: Uncompensated Advisor—BSCI, Intact Vascular, Intervene, MDT, Philips, Vesper Medical 

Dr. Murphy: Advisory Board—Boston Scientific, Medtronic, Philips, Vesper; Consultant—Boston Scientific, Cook, Medtronic, Philips, Vesper

Ms. Seaman: Speakers' Bureau—Next Science

Dr. Oettgen has disclosed no relevant financial relationships with any commercial interests.


North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

privacy policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.